IMA Advisory Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$561 Hold
1
﹤0.01% 850
2025
Q4
$676 Hold
1
﹤0.01% 826
2025
Q3
$639 Hold
1
﹤0.01% 390
2025
Q2
$536 Buy
+1
New +$478 ﹤0.01% 391
2023
Q4
Sell
-19
Closed -$8.31K 159
2023
Q3
$8.31K Hold
19
﹤0.01% 249
2023
Q2
$9.54K Hold
19
﹤0.01% 251
2023
Q1
$9.5K Hold
19
﹤0.01% 244
2022
Q4
$7.75K Hold
19
﹤0.01% 269
2022
Q3
$6K Hold
19
﹤0.01% 273
2022
Q2
$7K Hold
19
﹤0.01% 272
2022
Q1
$10K Hold
19
﹤0.01% 244
2021
Q4
$13K Hold
19
﹤0.01% 238
2021
Q3
$12K Hold
19
﹤0.01% 227
2021
Q2
$12K Hold
19
﹤0.01% 226
2021
Q1
$9K Hold
19
﹤0.01% 236
2020
Q4
$9K Hold
19
﹤0.01% 222
2020
Q3
$7K Hold
19
﹤0.01% 223
2020
Q2
$6K Hold
19
﹤0.01% 218
2020
Q1
$5K Hold
19
﹤0.01% 224
2019
Q4
$5K Hold
19
﹤0.01% 251
2019
Q3
$5K Hold
19
﹤0.01% 253
2019
Q2
$5K Hold
19
﹤0.01% 242
2019
Q1
$4K Hold
19
﹤0.01% 243
2018
Q4
$4K Hold
19
﹤0.01% 260
2018
Q3
$5K Hold
19
﹤0.01% 255
2018
Q2
$4K Buy
+19
New +$3.92K ﹤0.01% 347

Other funds holding IDXX

IMA Advisory Services's IDXX Position: Q1 2026 in Review

IMA Advisory Services held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 1 share worth $561. The position accounts for ﹤0.01% of the portfolio, ranked #850.

IMA Advisory Services first reported a position in IDXX in Q2 2018 and has held it in 26 quarters since. The position peaked at $13K in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • IMA Advisory Services held 1 share of Idexx Laboratories worth $561 as of Q1 2026.
  • IMA Advisory Services left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of IMA Advisory Services's portfolio in Q1 2026, its #850 holding.
  • IMA Advisory Services first reported a position in Idexx Laboratories in Q2 2018 and has held it in 26 quarters since.
  • IMA Advisory Services's Idexx Laboratories position peaked at $13K in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.